Cargando…

Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases

Introduction It is hypothesized that bronchoalveolar lavage (BAL) neutrophilia, Krebs von den Lungen-6 (KL-6), and C-reactive protein (CRP) predict the severity of chronic fibrosing interstitial lung diseases (CF-ILDs). Methods This cross-sectional study enrolled 30 CF-ILD patients. Using Pearson’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shadrach, Benhur Joel, Dutt, Naveen, Elhence, Poonam, Banerjee, Mithu, Chauhan, Nishant Kumar, Jalandra, Ram N, Garg, Mahendra Kumar, Garg, Pawan, Tandon, Abhishek, Shishir, Saumya, Kochar, Rishabh, Chhatwani, Bhavesh, Pareek, Piyush, Parrikar, Anika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439013/
https://www.ncbi.nlm.nih.gov/pubmed/37602059
http://dx.doi.org/10.7759/cureus.42162
_version_ 1785092845256835072
author Shadrach, Benhur Joel
Dutt, Naveen
Elhence, Poonam
Banerjee, Mithu
Chauhan, Nishant Kumar
Jalandra, Ram N
Garg, Mahendra Kumar
Garg, Pawan
Tandon, Abhishek
Shishir, Saumya
Kochar, Rishabh
Chhatwani, Bhavesh
Pareek, Piyush
Parrikar, Anika
author_facet Shadrach, Benhur Joel
Dutt, Naveen
Elhence, Poonam
Banerjee, Mithu
Chauhan, Nishant Kumar
Jalandra, Ram N
Garg, Mahendra Kumar
Garg, Pawan
Tandon, Abhishek
Shishir, Saumya
Kochar, Rishabh
Chhatwani, Bhavesh
Pareek, Piyush
Parrikar, Anika
author_sort Shadrach, Benhur Joel
collection PubMed
description Introduction It is hypothesized that bronchoalveolar lavage (BAL) neutrophilia, Krebs von den Lungen-6 (KL-6), and C-reactive protein (CRP) predict the severity of chronic fibrosing interstitial lung diseases (CF-ILDs). Methods This cross-sectional study enrolled 30 CF-ILD patients. Using Pearson’s correlation analysis, BAL neutrophils, KL-6, and CRP were correlated with forced vital capacity (FVC), diffusing lung capacity for carbon monoxide (DLCO), six-minute walk distance (6MWD), partial pressure of oxygen (PaO2), computed tomography fibrosis score (CTFS), and pulmonary artery systolic pressure (PASP). Using the receiver operator characteristic (ROC) curve, BAL KL-6 and CRP were evaluated against FVC% and DLCO% in isolation and combination with BAL neutrophilia for predicting the severity of CF-ILDs. Results BAL neutrophilia significantly correlated only with FVC% (r = -0.38, P = 0.04) and DLCO% (r = -0.43, P = 0.03). BAL KL-6 showed a good correlation with FVC% (r = -0.44, P < 0.05) and DLCO% (r = -0.50, P = 0.02), while BAL CRP poorly correlated with all parameters (r = 0.0-0.2). Subset analysis of BAL CRP in patients with CTFS ≤ 15 showed a better association with FVC% (r = -0.28, P = 0.05) and DLCO% (r = -0.36, P = 0.04). BAL KL-6 cut-off ≥ 72.32 U/ml and BAL CRP ≥ 14.55 mg/L predicted severe disease with area under the curve (AUC) values of 0.77 and 0.71, respectively. The combination of BAL neutrophilia, KL-6, and CRP predicted severity with an AUC value of 0.89. Conclusion The combination of BAL neutrophilia, KL-6, and CRP facilitates the severity stratification of CF-ILDs complementing existing severity parameters.
format Online
Article
Text
id pubmed-10439013
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104390132023-08-20 Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases Shadrach, Benhur Joel Dutt, Naveen Elhence, Poonam Banerjee, Mithu Chauhan, Nishant Kumar Jalandra, Ram N Garg, Mahendra Kumar Garg, Pawan Tandon, Abhishek Shishir, Saumya Kochar, Rishabh Chhatwani, Bhavesh Pareek, Piyush Parrikar, Anika Cureus Pulmonology Introduction It is hypothesized that bronchoalveolar lavage (BAL) neutrophilia, Krebs von den Lungen-6 (KL-6), and C-reactive protein (CRP) predict the severity of chronic fibrosing interstitial lung diseases (CF-ILDs). Methods This cross-sectional study enrolled 30 CF-ILD patients. Using Pearson’s correlation analysis, BAL neutrophils, KL-6, and CRP were correlated with forced vital capacity (FVC), diffusing lung capacity for carbon monoxide (DLCO), six-minute walk distance (6MWD), partial pressure of oxygen (PaO2), computed tomography fibrosis score (CTFS), and pulmonary artery systolic pressure (PASP). Using the receiver operator characteristic (ROC) curve, BAL KL-6 and CRP were evaluated against FVC% and DLCO% in isolation and combination with BAL neutrophilia for predicting the severity of CF-ILDs. Results BAL neutrophilia significantly correlated only with FVC% (r = -0.38, P = 0.04) and DLCO% (r = -0.43, P = 0.03). BAL KL-6 showed a good correlation with FVC% (r = -0.44, P < 0.05) and DLCO% (r = -0.50, P = 0.02), while BAL CRP poorly correlated with all parameters (r = 0.0-0.2). Subset analysis of BAL CRP in patients with CTFS ≤ 15 showed a better association with FVC% (r = -0.28, P = 0.05) and DLCO% (r = -0.36, P = 0.04). BAL KL-6 cut-off ≥ 72.32 U/ml and BAL CRP ≥ 14.55 mg/L predicted severe disease with area under the curve (AUC) values of 0.77 and 0.71, respectively. The combination of BAL neutrophilia, KL-6, and CRP predicted severity with an AUC value of 0.89. Conclusion The combination of BAL neutrophilia, KL-6, and CRP facilitates the severity stratification of CF-ILDs complementing existing severity parameters. Cureus 2023-07-19 /pmc/articles/PMC10439013/ /pubmed/37602059 http://dx.doi.org/10.7759/cureus.42162 Text en Copyright © 2023, Shadrach et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pulmonology
Shadrach, Benhur Joel
Dutt, Naveen
Elhence, Poonam
Banerjee, Mithu
Chauhan, Nishant Kumar
Jalandra, Ram N
Garg, Mahendra Kumar
Garg, Pawan
Tandon, Abhishek
Shishir, Saumya
Kochar, Rishabh
Chhatwani, Bhavesh
Pareek, Piyush
Parrikar, Anika
Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases
title Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases
title_full Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases
title_fullStr Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases
title_full_unstemmed Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases
title_short Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases
title_sort clinical utility of bronchoalveolar lavage neutrophilia and biomarkers for evaluating severity of chronic fibrosing interstitial lung diseases
topic Pulmonology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439013/
https://www.ncbi.nlm.nih.gov/pubmed/37602059
http://dx.doi.org/10.7759/cureus.42162
work_keys_str_mv AT shadrachbenhurjoel clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT duttnaveen clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT elhencepoonam clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT banerjeemithu clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT chauhannishantkumar clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT jalandraramn clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT gargmahendrakumar clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT gargpawan clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT tandonabhishek clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT shishirsaumya clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT kocharrishabh clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT chhatwanibhavesh clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT pareekpiyush clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases
AT parrikaranika clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases